Medical Devices APAC

APAC Glaucoma Surgery Devices Market Analysis, 2024–2034

APAC Glaucoma Surgery Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Procedure, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $317.1 Mn Estimated value
Estimate 2025 $348.5 Mn 24.4% of the global market
Projected 2034 $814.9 Mn 133.9% Adds $466.5 Mn over 9 forecast years
CAGR 2025–2034 9.9% Faster than 49% of 173 Medical Devices markets here
Key players 5
  • APAC is 24.44% of the global market.
  • Among regions, the largest is North America at $672.0 Mn.
  • Fastest growing: Africa at 10.6% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$466.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Glaucoma Surgery Devices Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $317.1 Mn — —
2025 (base) $348.5 Mn +$31.4 Mn —
2026 (forecast) $382.9 Mn +$34.5 Mn +9.9%
2027 (forecast) $420.9 Mn +$37.9 Mn +20.8%
2028 (forecast) $462.5 Mn +$41.7 Mn +32.7%
2029 (forecast) $508.3 Mn +$45.8 Mn +45.9%
2030 (forecast) $558.6 Mn +$50.3 Mn +60.3%
2031 (forecast) $613.9 Mn +$55.3 Mn +76.2%
2032 (forecast) $674.7 Mn +$60.8 Mn +93.6%
2033 (forecast) $741.5 Mn +$66.8 Mn +112.8%
2034 (forecast) $814.9 Mn +$73.4 Mn +133.9%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

The APAC Glaucoma Surgery Devices Market Analysis Executive Summary

Glaucoma surgery devices lower eye pressure using tiny stents, shunts and lasers, often during cataract surgery.

Key segments of the glaucoma Surgery Devices market include product (MIGS Devices, Glaucoma Drainage Devices and Laser Systems) and procedure (Standalone and Combined with Cataract Surgery).

APAC Glaucoma Surgery Devices Market Dynamics

Market Growth Drivers

An ageing population, more people with diabetes and long-term conditions, better treatments and wider access to specialist care are driving the glaucoma Surgery Devices market.

Opportunity

Longer-acting treatments, home-based care and screening in emerging markets give the glaucoma Surgery Devices market room to grow.

Market Restraints

High costs of new treatments, specialist shortages, low awareness and limited reimbursement in some countries hold back the glaucoma Surgery Devices market.

Competitive Landscape for Glaucoma Surgery Devices Market in APAC

The glaucoma Surgery Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Glaucoma Surgery Devices Market in APAC

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how glaucoma Surgery Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Glaucoma Surgery Devices right now, from free public sources.

Clinical trials

23 active trials in China, India, Japan, Australia, Hong Kong, Philippines, Singapore, Thailand, Malaysia, New Zealand, Bangladesh, Afghanistan, Indonesia, Myanmar, Nepal and Pakistan

Recruiting, about to start, or running now. Counted across the 16 countries we report on in APAC.

Top trial sponsors (worldwide)

  1. SpyGlass Pharma, Inc. 5 active trials on ClinicalTrials.gov (opens in a new tab)
  2. iSTAR Medical 5 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Glaukos 4 active trials on ClinicalTrials.gov (opens in a new tab)
  4. AbbVie Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  5. VividWhite Pty Ltd 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Glaucoma Surgery Devices in context

Questions, answered with public data

How many clinical trials on Glaucoma Surgery Devices are running in APAC?
23 studies are recruiting, active or about to start in APAC, counted across the 16 countries we report on there.[1]
How much research is published on Glaucoma Surgery Devices?
PubMed lists 916 papers added since January 2021 that match this market, worldwide.[2]

[1] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in APAC. Retrieved 12 Nov 2026.

[2] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on eye health

See the topic